Polysaccharide hydrogels for skin wound healing

M Liu, J Jin, X Zhong, L Liu, C Tang, L Cai - Heliyon, 2024 - cell.com
Advances in the development and utilization of polysaccharide materials are highly
promising, offering prominent applications in the field of tissue engineering for addressing …

HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis

S Katelani, GE Fragoulis, AD Bakasis… - …, 2023 - academic.oup.com
Objective The objective of this study was to assess the possibility of HBV reactivation (HBVr)
in patients with RA under anti-IL-6 treatment. Methods Using PubMed, Scopus and …

Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infection

WWY Tso, MYW Kwan, JSY Kwok… - Journal of Medical …, 2023 - Wiley Online Library
Omicron generally causes milder disease than previous strains of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), especially in fully vaccinated individuals. However …

Bioinspired asymmetric double-layer dressings for stepwise treatment of hemorrhagic wounds

J Yang, J Jia, X Wang, Y Zhao - ACS Materials Letters, 2024 - ACS Publications
Although various dressings have been developed for wound healing, ideal dressings are
still lacking to meet the requirements of coordinated hemostasis and angiogenesis for the …

Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping

H Tanaka, Y Okada, S Nakayamada… - Annals of the …, 2024 - ard.bmj.com
Objective Extracting immunological and clinical heterogeneity across autoimmune
rheumatic diseases (AIRDs) is essential towards personalised medicine. Methods We …

Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis

CC Drost, A Rovas, I Osiaevi, K Schughart, A Lukasz… - Angiogenesis, 2024 - Springer
Damage of the endothelial glycocalyx (eGC) plays a central role in the development of
vascular hyperpermeability and organ damage during systemic inflammation. However, the …

[HTML][HTML] Перспективы ингибиции интерлейкина-6 при ревматоидном артрите: олокизумаб (новые моноклональные антитела к ИЛ-6)

ЕЛ Насонов, Е Файст - Научно-практическая ревматология, 2022 - cyberleninka.ru
Ревматоидный артрит (РА)-хроническое иммуновоспалительное ревматическое
заболевание (ИВРЗ), проявляющееся прогрессирующей деструкцией суставов …

Successfully treated with siltuximab and prednisone in a 7-year-old girl with DOCK8-deficiency presenting as recurrent wart-like lesions: a case report

Z Sun, R Wei, C Pan, C Ni, X Zhang, W Guan… - Frontiers in …, 2024 - frontiersin.org
Dedicator of cytokinesis 8 (DOCK8) deficiency represents a primary immunodeficiency with
a wide range of clinical symptoms, including recurrent infections, atopy, and increased …

Фармакотерапия гигантоклеточного артериита и ревматической полимиалгии: перспективы применения моноклональных антител к интерлейкину 6

ЕЛ Насонов, АМ Сатыбалдыев… - Научно …, 2024 - rsp.mediar-press.net
Аннотация Гигантоклеточный артериит (ГКА) и ревматическая полимиалгия (РПМ)–
иммуновоспалительные ревматические заболевания (ИВРЗ), особенностью которых …

The latest advances in the use of biological DMARDs to treat Still's disease

I Di Cola, P Ruscitti - Expert Opinion on Biological Therapy, 2024 - Taylor & Francis
Introduction Currently, the therapeutic management of Still's disease, a multisystemic
inflammatory rare disorder, is directed to target the inflammatory symptoms and signs of …